- Home
- SPR vs HAE Comparison
SPR vs HAE Comparison
Compare SPR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPR
- HAE
- Stock Information
- Founded
- SPR 1927
- HAE 1971
- Country
- SPR United States
- HAE United States
- Employees
- SPR N/A
- HAE N/A
- Industry
- SPR Military/Government/Technical
- HAE Medical/Dental Instruments
- Sector
- SPR Industrials
- HAE Health Care
- Exchange
- SPR Nasdaq
- HAE Nasdaq
- Market Cap
- SPR 3.7B
- HAE 3.9B
- IPO Year
- SPR 2006
- HAE 1991
- Fundamental
- Price
- SPR $33.91
- HAE $73.49
- Analyst Decision
- SPR Hold
- HAE Strong Buy
- Analyst Count
- SPR 16
- HAE 9
- Target Price
- SPR $35.67
- HAE $108.78
- AVG Volume (30 Days)
- SPR 1.2M
- HAE 513.7K
- Earning Date
- SPR 02-04-2025
- HAE 02-06-2025
- Dividend Yield
- SPR N/A
- HAE N/A
- EPS Growth
- SPR N/A
- HAE N/A
- EPS
- SPR N/A
- HAE 2.41
- Revenue
- SPR $6,478,200,000.00
- HAE $1,361,223,000.00
- Revenue This Year
- SPR $6.60
- HAE $7.56
- Revenue Next Year
- SPR $25.00
- HAE $3.13
- P/E Ratio
- SPR N/A
- HAE $30.49
- Revenue Growth
- SPR 16.62
- HAE 9.84
- 52 Week Low
- SPR $25.16
- HAE $69.29
- 52 Week High
- SPR $37.08
- HAE $97.97
- Technical
- Relative Strength Index (RSI)
- SPR 57.44
- HAE 36.41
- Support Level
- SPR $33.61
- HAE $69.29
- Resistance Level
- SPR $34.44
- HAE $82.25
- Average True Range (ATR)
- SPR 0.63
- HAE 2.96
- MACD
- SPR -0.03
- HAE -0.32
- Stochastic Oscillator
- SPR 65.13
- HAE 32.41
About SPR Spirit Aerosystems Holdings Inc.
Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005, and the firm is the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.